Show simple item record

dc.contributor.authorÜnsal, Gülşah
dc.contributor.authorTunç, Gaffari
dc.contributor.authorTaştanoğlu, Hüseyin
dc.contributor.authorÇelik, Nurullah
dc.date.accessioned2024-03-06T06:05:21Z
dc.date.available2024-03-06T06:05:21Z
dc.date.issued2023tr
dc.identifier.urihttps://hdl.handle.net/20.500.12418/14712
dc.description.abstractAbstract. – OBJECTIVE: The aim of this study was to investigate the effect of Tropo nin-T levels on the prognosis of neonatal en cephalopathy (NE). PATIENTS AND METHODS: The study in cluded one hundred and eleven newborns diag nosed with NE and receiving hypothermia treat ment. The cases were separated into 2 groups according to the SARNAT classification as Stage 2 or Stage 3. The groups were compared in re spect of anthropometric characteristics, APGAR scores, and biochemical parameters. The cases were also separated into 3 groups according to the Troponin-T levels and were compared with respect to the clinical course. RESULTS: The serum Troponin-T (p=0.012), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (p<0.0001), and lac tate levels (p=0.04) in the Sarnat Stage 3 group were statistically significantly higher than in the Sarnat stage 2 group. A significant positive correlation was determined between the Tropo nin-T level and the total duration of respirato ry support (r=0.20, p=0.03). A significant pos itive correlation was determined between the ALT/AST ratio and the length of stay in hos pital (r=0.29, p=0.001), duration of intubation (r=0.32, p=0.01), and total duration of respira tory support (r=0.36, p<0.001). A statistically significant difference was determined in mor tality rates between the 3 subgroups of Tropo nin-T levels; Group 1: 2.8%, Group 2:5.4%, and Group 3: 15.8%. (p=0.04, χ²=4.74). A cut-off val ue of 164 ng/L for Troponin-T was determined to predict mortality with 77% sensitivity and 67% specificity (AUC=0.73, p=0.023). When the groups were compared according to Troponin-T level, a statistically significant difference was determined in respect of length of stay in hos pital (p=0.03, χ²=6.95) and total duration of ox ygen support (p=0.01, χ²=9.12). CONCLUSIONS: The serum Troponin-T level can be evaluated as a prognostic marker in cas es followed up with a diagnosis of NE and re ceiving hypothermia treatment. There is a need for further prospective studies with larger sam ples on this subject.tr
dc.language.isoengtr
dc.rightsinfo:eu-repo/semantics/openAccesstr
dc.titleTroponin-T value as a prognostic marker in neonates diagnosed with neonatal encephalopathy and receiving hypothermia treatmenttr
dc.typearticletr
dc.contributor.departmentTıp Fakültesitr
dc.contributor.authorID0000-0003-1583-6807tr
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıtr


Files in this item

This item appears in the following Collection(s)

Show simple item record